The U.S. minor cannabinoids market size is expected to reach USD 33.3 billion by 2030, expanding at a CAGR of 16.4% over the forecast period. Rising use of cannabinoid-based products and the increasing awareness regarding health benefits associated with consumption of these products are some of the crucial factors supporting the growth.
There is a growing interest among consumers in natural products that are perceived to be safer and healthier than synthetic alternatives. Thus. The increasing demand for natural products is likely to support industry expansion. Moreover, innovations and new product developments in the form of infused beverages, edibles, and topicals are further fueling the market’s growth. For instance, in February 2023, Harpoon Brewery launched its first THC-based beverage Rec Weed.
Minor cannabinoids have been found to have potential therapeutic benefits, including anti-inflammatory, analgesic, and neuroprotective effects. There is a growing interest in developing pharmaceuticals and nutraceuticals containing minor cannabinoids for the treatment of various medical conditions, such as chronic pain, anxiety, and sleep disorders. For instance, in January 2021, Lygos, Inc. announced the commercial availability of cannabichromene (CBC). CBC has a wide range of anti-inflammatory, antioxidant, and pain management properties.
In addition, minor cannabinoids are increasingly being incorporated into wellness products, including supplements, tinctures, and topicals. These products are marketed as natural remedies for a range of health issues and are popular among consumers looking for alternatives to traditional medications. For instance, one such product is Kriva from Nextraction. Kriva is one of the leading personal care products for health and wellness applications.
Furthermore, various organic and inorganic developments done by players to strengthen their business avenues and footprints in U.S. minor cannabinoids industry are anticipated to facilitate market expansion over the forecast period. For instance, in January 2022, Sugarmade, Inc. signed a binding Letter of Intent with GenCann, Inc. to enter the rare cannabinoid market. Thus, such initiatives are anticipated to cater to the demand throughout the forecast period.
This product will be delivered within 1-3 business days.
There is a growing interest among consumers in natural products that are perceived to be safer and healthier than synthetic alternatives. Thus. The increasing demand for natural products is likely to support industry expansion. Moreover, innovations and new product developments in the form of infused beverages, edibles, and topicals are further fueling the market’s growth. For instance, in February 2023, Harpoon Brewery launched its first THC-based beverage Rec Weed.
Minor cannabinoids have been found to have potential therapeutic benefits, including anti-inflammatory, analgesic, and neuroprotective effects. There is a growing interest in developing pharmaceuticals and nutraceuticals containing minor cannabinoids for the treatment of various medical conditions, such as chronic pain, anxiety, and sleep disorders. For instance, in January 2021, Lygos, Inc. announced the commercial availability of cannabichromene (CBC). CBC has a wide range of anti-inflammatory, antioxidant, and pain management properties.
In addition, minor cannabinoids are increasingly being incorporated into wellness products, including supplements, tinctures, and topicals. These products are marketed as natural remedies for a range of health issues and are popular among consumers looking for alternatives to traditional medications. For instance, one such product is Kriva from Nextraction. Kriva is one of the leading personal care products for health and wellness applications.
Furthermore, various organic and inorganic developments done by players to strengthen their business avenues and footprints in U.S. minor cannabinoids industry are anticipated to facilitate market expansion over the forecast period. For instance, in January 2022, Sugarmade, Inc. signed a binding Letter of Intent with GenCann, Inc. to enter the rare cannabinoid market. Thus, such initiatives are anticipated to cater to the demand throughout the forecast period.
U.S. Minor Cannabinoids Market Report Highlights
- The U.S. minor cannabinoids industry size is anticipated to be valued at USD 33.3 billion by 2030, owing to rising health benefits from cannabis-derived products and supportive legislative norms
- THCV dominated with the highest revenue share in 2022 with a share of 25.5%, owing to the increasing application of THCV in the management of conditions such as arthritis, metabolic disorders, and epilepsy
- In 2022, by application. The others segment accounted for the highest share of 34.8%, owing to the increasing burden of target diseases and rising applications of cannabinoids in the management of such conditions
This product will be delivered within 1-3 business days.
Frequently Asked Questions about the U.S. Minor Cannabinoids Market
What is the estimated value of the U.S. Minor Cannabinoids Market?
What is the growth rate of the U.S. Minor Cannabinoids Market?
What is the forecasted size of the U.S. Minor Cannabinoids Market?
Who are the key companies in the U.S. Minor Cannabinoids Market?
Report Attribute | Details |
---|---|
No. of Pages | 80 |
Published | April 2023 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 9.2 Billion |
Forecasted Market Value ( USD | $ 33.3 Billion |
Compound Annual Growth Rate | 16.4% |
Regions Covered | United States |
No. of Companies Mentioned | 11 |
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 U.S. Minor Cannabinoids Market Variables, Trends & Scope
Chapter 4 U.S. Minor Cannabinoids Market: Competitive Landscape Analysis
Chapter 5 U.S. Minor Cannabinoids Market: Product Estimates & Trend Analysis
Chapter 6 U.S. Minor Cannabinoids Market: Application Estimates & Trend Analysis
Chapter 7 Company Profiles
List of Tables
List of Figures
Companies Mentioned
- Mile High Labs
- Global Cannabinoids
- GenCanna
- CBD Inc.
- Precision Plant Molecules
- Rhizo Sciences
- LaurelCrest
- Fresh Bros Hemp Company
- BulKanna
- High Purity Natural Products
- ZERO POINT EXTRACTION, LLC
Methodology
LOADING...